WE’RE TAKING
NEUROLOGY
TO
A WHOLE NEW
LEVEL
Eisai Neurology is aiming to revolutionize drug discovery and develop targeted medicines for some of the world’s most challenging neurological conditions. Read how our dedication and patient interactions influence our approach and help us create hope through innovation.
NEWS AND BREAKTHROUGHS
Read the latest on how we're helping people living with neurodegenerative diseases.
WE’RE ON A MISSION TO PREVENT AND EVEN REVERSE ALZHEIMER’S DISEASE (AD)
Our four-decade-long commitment to addressing AD grows naturally from our human health care mission. It’s one of society’s greatest unmet medical needs, and we’re determined to find precision solutions that go beyond treatment, to prevention and reversal. To that end, we’ve amassed an unparalleled set of capabilities:
- We’re the only company with programs targeting amyloid (the main component of plaques found in the brains of people with AD); tau (a protein that’s vital to brain health); neurodegeneration; inflammation; and the clinical symptoms of dementia, such as cognition and sleep-wake disorders.
- Our rich pipeline includes a wide scope of investigational compounds and diagnostic methods being researched in AD. In addition, we’re exploring novel therapies designed to address clinical symptoms such as cognition and sleep disorders.
- Eisai is researching disease-modifying compounds for potential treatment of AD.
- Our ground-breaking Center for Genetics Guided Dementia Discovery (G2D2) is focused on delivering a new generation of immunodementia drugs that can bolster the body’s immunity against dementia.
We’re proud to have dedicated more than 30 years to research, development and commercialization in our relentless pursuit of treatments for Alzheimer’s
disease and dementia.”
DISCOVER HOW WE’RE BREAKING THROUGH
FOR
PEOPLE LIVING WITH:
ONE TEAM
Looking for a team environment where you’ll be challenged to break through? Join our human health care mission to make a difference in the lives of patients.
